GLP-1 assays optimized for the Gyrolab® platform compare favorably to Mesoscale Discovery (MSD) assays for GLP-1
Previously, we showed that the newly developed GLP-1 assays for the Gyrolab® platform were well-correlated to our widely published and cited GLP-1 ELISAs (data presented at the Gyrolab® Users Meeting, 2014). In this study, we compared our Gyrolab® platform assays to commercially available GLP-1 assays for the Mesoscale Discovery (MSD) platform in order to demonstrate assay specificity, sensitivity and precision.Download Application Note
Novel Rat Kidney Injury Biomarker Assays Using a Gyros Nanotechnology Platform
We have developed the GyroMark™ HT Rat KIM-1 and Rat Clusterin Assay Kits, which will provide customers with new tools needed to perform nephrotoxicity screening during drug development and toxicity research on the Gyrolab® platform, one of the most rapid immunoassay platforms available for high-throughput screening.
Good Correlation Between Measured Cytokine Levels Using Multiplexed Bead-based Detection and ELISA Platforms
Here we compare sample data from a bead-based immunoassay (MILLIPLEX® MAP Human Cytokine/Chemokine Magnetic Bead Panel 1) with data from cytokine ELISAs, showing correlation in samples from normal subjects and sepsis patients.Download Application Note